High-grade astrocytoma in very young children

Pediatric Blood and Cancer

Volumn 49, Issue 7, 2007, Pages 888-893

  Sanders, Robert P ^a   Kocak, Mehmet ^a   Burger, Peter C ^b   Merchant, Thomas E ^a   Gajjar, Amar ^a   Broniscer, Alberto ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumors; Late effects of cancer treatment; Neuro oncology; Neurotoxicity of therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; ENDOCRINE DISEASE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HISTOLOGY; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SCHOOL; TREATMENT INDICATION; TREATMENT OUTCOME; TUMOR BIOPSY;

AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 35648934426     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21272     Document Type: Article

References (30)

1. CBTRUS (2005). Statistical report: Primary brain tumors in the United States, 1998-2002. 2005; www.cbtrus.org.
2. Geyer JR, Finlay JL, Boyett JM, et al. Survival of infants with malignant astrocytomas. A Report from the Childrens Cancer Group. Cancer 1995;75:1045-1050.
3. Duffner PK, Krischer JP, Burger PC, et al. Treatment of infants with malignant gliomas: The Pediatric Oncology Group experience. J Neurooncol 1996;28:245-256.
4. Dufour C, Grill J, Lellouch-Tubiana A, et al. High-grade glioma in children under 5 years of age: A chemotherapy only approach with the BBSFOP protocol. Eur J Cancer 2006;42:2939-2945.
5. McCarthy D. McCarthy scales of children's abilities. New York, NY: The Psychological Corporation, 1972.
6. Bayley N. Bayley scales of infant development, 2nd edition. New York, NY: The Psychological Corporation, 1993.
7. Wechsler D. Wechsler intelligence scale for children, 3rd (WISC-III) edition. San Antonio, TX: The Psychological Corporation, 1991.
8. Wechsler D. Wechsler adult intelligence scale, 3rd edition. San Antonio, TX: The Psychological Corporation, 1997.
9. Wechsler D. Wechsler abbreviated scale of intelligence. San Antonio, TX: The Psychological Corporation, 1999.
10. Wechsler D. Wechsler preschool and primary scale of intelligence, 3rd edition. San Antonio, TX: The Psychological Corporation, 2002.
11. Sparrow SS, Balla DA, Cicchetti DV. Vineland adaptive behavior scales. Circle Pines, MN: American Guidance Service, 1984.
12. Jastak S, Wilkinson GS. Wide range achievement test - Revised. Wilmington, DE: Wide Range, 1984.
13. Wilkinson GS. Wide range achievement test, 3rd edition. Wilmington, DE: Wide Range, 1993.
14. Woodcock RW, McGrew KS, Mather N. Woodcock-Johnson Tests of Achievement III. Itasca, IL: Riverside, 2001.
15. Wechsler D. Wechsler individual achievement test. San Antonio, TX: The Psychological Corporation, 1992.
16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
17. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley, 1980.
18. Cox DR. Regression models and life tables. J Royal Stat Soc Ser B 1972;34:187-220.
19. Heideman RL, Kuttesch J, Jr., Gajjar AJ, et al. Supratentorial malignant gliomas in childhood: A single institution perspective. Cancer 1997;80:497-504.
20. van Eys J, Cangir A, Coody D, et al. MOPP regimen as primary chemotherapy for brain tumors in infants. J Neurooncol 1985;3:237-243.
21. Kovnar EH, Kellie SJ, Horowitz ME, et al. Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: A phase II study. J Clin Oncol 1990;8:330-336.
22. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;328:1725-1731.
23. Razzouk BI, Heideman RL, Friedman HS, et al. A phase II evaluation of thiotepa followed by other multiagent chemotherapy regimens in infants and young children with malignant brain tumors. Cancer 1995;75:2762-2767.
24. Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 1995;13:112-123.
25. Pollack IF, Hamilton RL, Finkelstein SD, et al. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 1997;57:304-309.
26. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 1999;17:3720-3728.
27. Duffner PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist 2004;10:293-310.
28. Duffner PK, Cohen ME, Thomas PR, et al. The long-term effects of cranial irradiation on the central nervous system. Cancer 1985;56:1841-1846.
29. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol 2005;23:7152-7160.
30. Merchant TE, Kiehna EN, Li C, et al. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys 2005;63:1546-1554.